Scott E Woodman Selected Research

Mesothelioma

11/2021

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott E Woodman Research Topics

Disease

42	Neoplasms (Cancer) 05/2024 - 07/2003
36	Melanoma (Melanoma, Malignant) 01/2023 - 12/2008
8	Uveal melanoma 10/2019 - 01/2012
7	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2009
4	Disease Progression 01/2018 - 11/2015
3	COVID-19 01/2023 - 10/2022
2	Infections 01/2023 - 12/2022
2	Cardiomegaly (Heart Hypertrophy) 02/2003 - 06/2002
1	Colorectal Neoplasms (Colorectal Cancer) 05/2024
1	Adenocarcinoma 05/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024
1	Delirium 01/2023
1	Overweight 01/2023
1	Thrombosis (Thrombus) 10/2022
1	Critical Illness (Critically Ill) 10/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Mesothelioma 11/2021
1	Headache (Headaches) 01/2018
1	Chills 01/2018
1	Fever (Fevers) 01/2018
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Carcinogenesis 01/2016

Drug/Important Bio-Agent (IBA)

14	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2016
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2002
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 11/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 12/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2009
4	Messenger RNA (mRNA)IBA 10/2021 - 01/2016
4	IpilimumabIBA 01/2017 - 01/2011
3	Bevacizumab (Avastin)FDA Link 05/2024 - 11/2021
3	atezolizumabIBA 05/2024 - 11/2021
3	trametinibIBA 01/2021 - 08/2012
3	Caveolin 1IBA 01/2005 - 02/2003
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2021
2	dabrafenibIBA 01/2021 - 01/2018
2	Phosphotransferases (Kinase)IBA 10/2019 - 02/2003
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2010
2	HLA-A Antigens (HLA-A)IBA 01/2018 - 01/2017
2	Interleukin-2 (IL2)IBA 01/2018 - 08/2014
2	Differentiation AntigensIBA 01/2017 - 01/2013
2	AntigensIBA 01/2017 - 01/2011
2	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 12/2008
2	Dasatinib (BMS 354825)FDA Link 11/2012 - 08/2009
2	Mitogen-Activated Protein KinasesIBA 08/2012 - 11/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2010 - 08/2009
2	Caveolin 3IBA 11/2003 - 10/2002
1	PlatinumIBA 02/2024
1	RamucirumabIBA 02/2024
1	Docetaxel (Taxotere)FDA Link 02/2024
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	CarbonIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	Long Noncoding RNAIBA 01/2022
1	Dietary Fiber FDA Link 12/2021
1	Keratins (Keratin)IBA 10/2021
1	Immune Checkpoint ProteinsIBA 10/2021
1	Polycomb Repressive Complex 2IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Histones (Histone)IBA 01/2021
1	ChromatinIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	Blocking AntibodiesIBA 01/2018
1	Interleukin-9 (Interleukin 9)IBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Investigational DrugsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2017
1	HLA-A*02:01 antigenIBA 01/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2017
1	EpitopesIBA 01/2017
1	pembrolizumabIBA 10/2016
1	CytokinesIBA 02/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 01/2016
1	immune RNA (I-RNA)IBA 10/2015
1	Adenosine (Adenocard)FDA LinkGeneric 10/2015
1	Inosine FDA Link 10/2015
1	pertuzumabIBA 09/2015
1	Neuregulin-1 (Neuregulin 1)IBA 09/2015
1	LigandsIBA 09/2015
1	Checkpoint Kinase 1IBA 09/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2014
1	Temozolomide (Temodar)FDA LinkGeneric 08/2014
1	Cisplatin (Platino)FDA LinkGeneric 08/2014
1	AlbuminsIBA 08/2014

Therapy/Procedure

33	Therapeutics 02/2024 - 09/2010
10	Immunotherapy 02/2024 - 11/2012
6	Drug Therapy (Chemotherapy) 05/2024 - 09/2014
2	Aftercare (After-Treatment) 01/2019 - 08/2014
2	Precision Medicine 01/2017 - 01/2016
1	Mechanical Ventilators (Ventilator) 12/2022
1	Length of Stay 10/2022
1	Artificial Respiration (Mechanical Ventilation) 10/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Withholding Treatment 01/2017